Company Poniard Pharmaceuticals, Inc. Other OTC
Equities
PARD
US7324494001
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,499,232 | 37,481 ( 2.500 %) | 0 | 2.500 % |
Stock B | 0 | 78,768 | 0 | 0 |
Company contact information
Poniard Pharmaceuticals, Inc.
300 Elliott Avenue West Suite 530
98119, Seattle
+
![address Poniard Pharmaceuticals, Inc.(PARD)](https://cdn.zonebourse.com/static/address/9730917.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+2.87% | 94.22B | |
-4.08% | 37.76B | |
-13.99% | 32.5B | |
+73.38% | 27.75B | |
-11.49% | 16.13B | |
-1.80% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |